INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Medable patient expo]( "Together, We Are On A Mission: Enabling Treatments To Reach Patients")
Together, We Are On A Mission: Enabling Treatments To Reach PatientsThis AI-powered digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.
-
![avance clinical_videoframe_0 (1)]( "The Phase 2 Endpoint Dilemma")
The Phase 2 Endpoint DilemmaPhase 2 neuro endpoints can miss subtle change. Learn when composites help or hinder, how to align cognition, function, and biomarkers with real-world data for go/no-go decisions.
-
![patient-voice-GettyImages-1367871743]( "Optimizing The Path From First-In-Human To Proof-Of-Concept")
Optimizing The Path From First-In-Human To Proof-Of-ConceptBy collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.
-
![Bring RTSM In A Protocol Synopsis Here's Why]( "Bring RTSM In A Protocol Synopsis: Here's Why")
Bring RTSM In A Protocol Synopsis: Here's WhyLearn how early feedback from experienced teams can reveal hidden protocol and logistical risks, helping sponsors refine decisions and avoid avoidable challenges long before the final protocol is set.
-
Reduction Of Screen Failures In A Biomarker2/24/2026
Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.
-
10 Ways To Elevate Your Investigators' Meeting6/26/2024
Learn how you can take your next Investigators' Meeting from every day to exceptional with 10 top tips from the clinical meeting planning experts at Scout.
-
Faster Starts, Stronger Finish: Operational Excellence In NSCLC5/22/2026
In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.
-
The Neural Crystal Ball: Forecasting Future CNS Drug Development4/15/2026
Advances in the industry are redefining how we treat neurological and psychiatric disorders. In this presentation, Dr. Beatrice Setnik examines the trends and innovations shaping the next generation of therapies.
-
Avoiding The Gotchas: RTSM Build Tips From A Seasoned PM3/25/2026
Small protocol details can create outsized challenges when definitions are unclear or when integrations aren’t planned early.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Medicine-pills-tablets-GettyImages-545993684]( "Human Abuse Potential")
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
![GettyImages-1293772969 lab testing]( "How ClinicReady Delivers Foundations For Success")
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
-
![Global networking healthcare-GettyImages-1477437266]( "Engaging, Empowering & Supporting Research Sites Around The World")
Accelerate trial timelines and recruitment while reducing site burden through this site network solution.
-
![Patient Satisfaction survey-GettyImages-1356228571]( "Elevating Success: The Crucial Role Of Customer Satisfaction Programs In Companies")
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
![GettyImages-165180340-digital-recruitment-people-patients]( "Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle")
Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
